
Cyclin-dependent kinase 2 - Wikipedia
Cyclin-dependent kinase 2, also known as cell division protein kinase 2, or Cdk2, is an enzyme that in humans is encoded by the CDK2 gene. [5] [6] The protein encoded by this gene is a …
Inhibition of the CDK2 and Cyclin A complex leads to autophagic ...
2022年5月20日 · Cyclin-dependent kinase 2 (CDK2) complex is significantly over-activated in many cancers. While it makes CDK2 an attractive target for cancer therapy, most inhibitors …
CDK2 Gene - GeneCards | CDK2 Protein | CDK2 Antibody
2024年12月24日 · CDK2 (Cyclin Dependent Kinase 2) is a Protein Coding gene. Diseases associated with CDK2 include Breast Cancer and Endometrial Hyperplasia. Among its related …
Cyclin-Dependent Kinases (CDK) and Their Role in Diseases …
In dividing cells, cyclin-dependent kinase 2 (CDK2) is a major cell cycle component that controls the G1/S and S/G2 transitions.
Targeting CDK2 in cancer: challenges and opportunities for therapy
CDK2 and its regulatory subunits are deregulated in many human cancers and there is emerging evidence suggesting CDK2 inhibition elicits antitumor activity in a subset of tumors with …
Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology …
Cyclin dependent kinase 2 (CDK2) is responsible for enforcing progression through the G1-S phase transition. Mutations and alterations in the CDK2 signaling pathway are associated with …
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An …
2019年5月9日 · Cyclin-dependent kinase 2 (CDK2) drives the progression of cells into the S- and M-phases of the cell cycle. CDK2 activity is largely dispensable for normal development, but it …
Cyclin-Dependent Kinase 2 - an overview | ScienceDirect Topics
Cyclin-dependent kinase 2 (CDK2) is a protein kinase that is essential for controlling cell division and the cell cycle. CDK2 dysregulation has been linked to several cancer forms, leading to it …
A novel landscape of nuclear human CDK2 substrates revealed
2020年4月17日 · Cyclin-dependent kinase 2 (CDK2) controls cell division and is central to oncogenic signaling. We used an “in situ” approach to identify CDK2 substrates within nuclei …
Discrete vulnerability to pharmacological CDK2 inhibition is …
2025年2月9日 · Here, the authors investigate CDK2-dependancy and response to CDK2 inhibition across different cancers, identifying markers of sensitivity and combinatorial therapeutic …